Clinical Chemistry, Vol 42, 1621-1626, Copyright © 1996 by American Association for Clinical Chemistry

Standardization of pyridinium crosslinks, pyridinoline and deoxypyridinoline, for use as biochemical markers of collagen degradation

SP Robins, A Duncan, N Wilson and BJ Evans
Rowett Research Institute, Biochemical Sciences Division, Bucksburn, Aberdeen, UK. S.Robins@rri.sari.ac.uk

The collagen crosslinks, pyridinoline and deoxypyridinoline, have been developed as urinary markers of bone resorption but, despite wide clinical application of the technique, comparatively little attention has been paid to the standardization of these compounds. In this study, pyridinoline and deoxypyridinoline have been purified from bone and converted completely to monochloride trihydrochloride salts. In addition to mass spectrometry and NMR spectroscopy, the purity of the isolated materials was assessed by microelemental analysis including the chloride counterions. These purified compounds were used to establish individual molar absorptivity values as primary standardization criteria for the two crosslinks. For pyridinoline in 0.1 mol/L HCl, epsilon at 295 nm was 5490 L mol(-1) cm(-1); in 50 mmol/L sodium phosphate, pH 7.5, epsilon at 325 nm was 5785. The corresponding values for deoxypyridinoline at acid and neutral pH were 5160 and 5290 L mol(-1) cm(-1). The availability of standardization criteria for the crosslinks will allow more meaningful comparisons of clinical data between different laboratories.

The following articles in journals at HighWire Press have cited this article:

				A. J. van der Slot, A.-M. Zuurmond, A. F. J. Bardoel, C. Wijmenga, H. E. H. Pruijs, D. O. Sillence, J. Brinckmann, D. J. Abraham, C. M. Black, N. Verzijl, et al. Identification of PLOD2 as Telopeptide Lysyl Hydroxylase, an Important Enzyme in Fibrosis J. Biol. Chem., October 17, 2003; 278(42): 40967 - 40972. [Abstract] [Full Text] [PDF]

				H. W. Vesper, S. J. Smith, C. Audain, and G. L. Myers Comparison Study of Urinary Pyridinoline and Deoxypyridinoline Measurements in 13 US Laboratories Clin. Chem., November 1, 2001; 47(11): 2029 - 2031. [Full Text] [PDF]

				R. A. Bank, S. P. Robins, C. Wijmenga, L. J. Breslau-Siderius, A. F. J. Bardoel, H. A. Van der Sluijs, H. E. H. Pruijs, and J. M. TeKoppele Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: Indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17 PNAS, February 2, 1999; 96(3): 1054 - 1058. [Abstract] [Full Text] [PDF]

				T. G. Rosano, R. T. Peaston, H. G. Bone, H. W. Woitge, R. M. Francis, and M. J. Seibel Urinary free deoxypyridinoline by chemiluminescence immunoassay: analytical and clinical evaluation Clin. Chem., October 1, 1998; 44(10): 2126 - 2132. [Abstract] [Full Text] [PDF]

				I. Fermo, C. Arcelloni, E. Casari, and R. Paroni Urine Pyridinium Cross-Links Determination by Beckman Cross Links Kit Clin. Chem., November 1, 1997; 43(11): 2186 - 2187. [Full Text]